Head of Pfizer booed by Trump supporters At a Black History Month reception in Washington, DC, Trump shouted out the head of Pfizer, Albert Bourla, who was met with relentless booing. #news #trump #pfizer #politics #blackhistorymonth #washingtondc Daily Mail Website: Daily Mail Facebook: Daily Mail IG: Daily Mail

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing soft demand from patients and their doctors.

Less than a year after approval, Pfizer said it plans to discontinue its hemophilia B gene therapy fidanacogene elaparvovec (Beqvez) across all global markets, citing weak demand. "Pfizer has made the decision to cease further development and commercialization activities with respect to Beqvez for several reasons,

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia B product Beqvez.